Back
Genelux 10K Form
Sell
46
GNLX
Genelux
Last Price:
$3.47
Seasonality Move:
9.99%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GNLX News And Ratings
See the #1 stock for the next 7 days that we like better than GNLX
GNLX Financial Statistics
Sales & Book Value
| Annual Sales: | $8K |
|---|---|
| Cash Flow: | $-7.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.64 |
| Price / Book: | 5.63 |
Profitability
| EPS (TTM): | -0.86000 |
|---|---|
| Net Income (TTM): | $-30.4M |
| Gross Margin: | $-895K |
| Return on Equity: | -100.78% |
| Return on Assets: | -79.39% |
Genelux Earnings Forecast
Key Genelux Financial Ratios
-
The Gross Profit Margin over the past 4 years for GNLX is -11,187.50%.
-
The Selling, General & Administrative Expenses for GNLX have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 237,475.00% of Revenue.
-
The Net Earning history of GNLX is -373,362.50% of Total Revenues.
-
Per Share Earnings over the last 5 years have been positive in 2 years.
Genelux Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | GNLX |
| Website: | genelux.com |
Debt
| Debt-to-Equity Ratio: | 0.07 |
|---|---|
| Current Ratio: | 4.18 |
| Quick Ratio: | 4 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |